z-logo
open-access-imgOpen Access
HIV-Infected Hospitalized Patients with 2009 Pandemic Influenza A (pH1N1)—United States, Spring and Summer 2009
Author(s) -
Philip J. Peters,
Jacek Skarbinski,
Janice K. Louie,
Seema Jain,
Michelle E. Roland,
Shilpa G. Jani,
Lyn Finelli,
John T. Brooks
Publication year - 2010
Publication title -
clinical infectious diseases
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 3.44
H-Index - 336
eISSN - 1537-6591
pISSN - 1058-4838
DOI - 10.1093/cid/ciq036
Subject(s) - medicine , intensive care unit , pandemic , population , human mortality from h5n1 , virus , human immunodeficiency virus (hiv) , pediatrics , virology , emergency medicine , covid-19 , disease , infectious disease (medical specialty) , environmental health
We describe the clinical findings of HIV-infected patients hospitalized with 2009 pandemic influenza A (pH1N1). Data were derived from 3 separate case series in the United States. Among 911 adults hospitalized with pH1N1 influenza, 31 (3.4%) were HIV infected compared with an HIV prevalence of 0.45% in the general US adult population. HIV-infected influenza patients experienced similar rates of intensive care unit admission (29% vs 34%) and death (13% vs 13%) compared with non-HIV-infected patients. Among HIV-infected patients with available data, 14 (50%) of 28 patients had a CD4 cell count <200 cells/μL, which was not associated with an increased risk of an intensive care unit admission or death. Overall, 25 (81%) HIV-infected patients received influenza antiviral therapy, but treatment was initiated within 48 h of illness onset in only 33% of cases. Clinicians should consider early empiric influenza antiviral treatment in HIV-infected patients presenting with suspected influenza.

The content you want is available to Zendy users.

Already have an account? Click here to sign in.
Having issues? You can contact us here
Accelerating Research

Address

John Eccles House
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom